Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs



G8 Timetable

G8Here is the timetable, as far as we know it, for the G8 Summit in Gleneagles.

July 6-8, 2005
Gleaneagles Summit

June 10-11, 2005
G7 Finance Ministers and Central Bank Governors Meeting, London

April 15
G7 Finance Ministers and Central Bank Governorns Meeting, Washington

March 7-8
Africa Partners Forum, Abuja, Nigeria

Making Markets for Vaccines - Online Resources

  • Full text of Making Markets for Vaccines report
  • Four page brief Making Markets for Vaccines
  • FAQ on Making Markets for Vaccines
  • Full transcript of launch of Making Markets for Vaccines
  • Making Markets for Vaccines web page
  • Making Markets for Vaccines Press Release

Merck Files for FDA Approval for Rotavirus Vaccine

Merck has filed for approval for Rotateq, its vaccine to protect against rotavirus gastroenteritis. Merck also announced that it has plans to file for licensure of Rotateq in Australia, Canada, the EU and Mexico, as well as countries in Asia and Latin America in 2005.

More information:

Maurice Hilleman 1919-2005

Maurice HillemanMaurice Hilleman died yesterday. Dr Hilleman was a researcher at Merck & Co until 1984, played a key role in the development of many vaccines, including mumps, measles, chickenpox, pneumonia, meningitis and other diseases, saving tens of millions of lives.

50th Anniversary of Polio Vaccine

Maurice HillemanOn April 12th, 1955, at a convocation at the University of Michigan, it was announced that the polio virus vaccine developed by Jonas Salk at the University of Pittsburgh was safe, effective and potent. Headlines around the world proclaimed "The Vaccine Works". The nickels and dimes that millions of Americans had donated to the March of Dimes had succeeded.

Tiered Prices: A Subsidy?

There is an interesting discussion unfolding on whether tiered prices for pharmaceuticals constitute a subsidy by Americans.